Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cristoferi

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Disease Markers|February 21, 2020
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis"Laura Cristoferi, Pietro Invernizzi
Journal of Hepatology|June 10, 2021
Transient elastography in chronic liver disease: Beware of the cut-offs!Laura Cristoferi, Alessandra Nardi, Marco Carbone
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2021
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should knowLaura Cristoferi, Alessio Gerussi, Pietro Invernizzi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2022
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing CholangitisJennifer Christine Halma, Laura Cristoferi, Marco Carbone
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Geoepidemiology and (epi-)genetics in primary biliary cholangitisRoberto Rosa, Laura Cristoferi, Atsushi Tanaka, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatGiulia Bonato, Laura Cristoferi, Mario Strazzabosco, et al.
Journal of Translational Autoimmunity|January 10, 2022
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?Giacomo Mulinacci, Andrea Palermo, Laura Cristoferi, et al.
Journal of Digestive Diseases|May 18, 2019
Precision medicine in primary biliary cholangitisVincenzo Ronca, Alessio Gerussi, Laura Cristoferi, et al.
Current Opinion in Immunology|July 19, 2025
Primary sclerosing cholangitis: what is new in the therapeutic landscapeArmando Curto, Laura Cristoferi, Marco Carbone, et al.
Surgical Oncology Clinics of North America|November 24, 2019
Individualizing Care: Management Beyond Medical TherapyLaura Cristoferi, Alessandra Nardi, Pietro Invernizzi, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Disease Markers|February 21, 2020
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis"Laura Cristoferi, Pietro Invernizzi
Journal of Hepatology|June 10, 2021
Transient elastography in chronic liver disease: Beware of the cut-offs!Laura Cristoferi, Alessandra Nardi, Marco Carbone
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2021
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should knowLaura Cristoferi, Alessio Gerussi, Pietro Invernizzi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2022
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing CholangitisJennifer Christine Halma, Laura Cristoferi, Marco Carbone
Best Practice & Research. Clinical Gastroenterology|October 23, 2018
Geoepidemiology and (epi-)genetics in primary biliary cholangitisRoberto Rosa, Laura Cristoferi, Atsushi Tanaka, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2015
Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatGiulia Bonato, Laura Cristoferi, Mario Strazzabosco, et al.
Journal of Translational Autoimmunity|January 10, 2022
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?Giacomo Mulinacci, Andrea Palermo, Laura Cristoferi, et al.
Journal of Digestive Diseases|May 18, 2019
Precision medicine in primary biliary cholangitisVincenzo Ronca, Alessio Gerussi, Laura Cristoferi, et al.
Current Opinion in Immunology|July 19, 2025
Primary sclerosing cholangitis: what is new in the therapeutic landscapeArmando Curto, Laura Cristoferi, Marco Carbone, et al.
Surgical Oncology Clinics of North America|November 24, 2019
Individualizing Care: Management Beyond Medical TherapyLaura Cristoferi, Alessandra Nardi, Pietro Invernizzi, et al.
Pageof 7